menu
    • menu

    Company profile for Regimmune

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    REGiMMUNE is a clinical-stage biopharmaceutical company focused on creating innovative immunotherapies for rare diseases and cancer by leveraging underexploited biological opportunities. We specifically target well-characterized biological pathways with compelling scientific data supporting their importance in regulating the immune response against disease. To target new pathways, we are building a robust and highly efficient ...
    REGiMMUNE is a clinical-stage biopharmaceutical company focused on creating innovative immunotherapies for rare diseases and cancer by leveraging underexploited biological opportunities. We specifically target well-characterized biological pathways with compelling scientific data supporting their importance in regulating the immune response against disease. To target new pathways, we are building a robust and highly efficient discovery capability to create and optimize highly differentiated biologic product candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RegimmuneTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    8F-8, 41 Nanjing W. Road., Datong District, Taipei 103
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://regimmune.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    REGiMMUNE, Kiji merge to create Treg 'super company,' plan IPO
    REGiMMUNE, Kiji merge to create Treg 'super company,' plan IPO

    18 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/regimmune-kiji-merge-create-treg-super-company-ahead-ipo

    FIERCE BIOTECH
    18 Oct 2024
    Share Share
    Regimmune Licenses the Rights to Develop RGI-2001 To San Fu
    Regimmune Licenses the Rights to Develop RGI-2001 To San Fu

    01 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230401005026/en

    BUSINESSWIRE
    01 Apr 2023
    Share Share
    REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction
    REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction

    20 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221219005846/en

    BUSINESSWIRE
    20 Dec 2022
    Share Share
    REGiMMUNE touts 'compelling' data in stem call transplants
    REGiMMUNE touts 'compelling' data in stem call transplants

    20 Dec 2022

    // James Waldron FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/regimmune-touts-compelling-phase-2-data-stem-call-transplant-patients-readies-phase-3

    James Waldron FIERCEBIOTECH
    20 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search